Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin may help with nerve pain, a hepatitis C drug is effective but has side effects, a treatment for mouth sores works but can cause blood issues, ear reconstruction with an implant is safe, HIV transmission from mother to child in Taiwan is now 0% with treatment, certain blood problems are more common in people with a tongue condition, a gene and being overweight are linked to hair loss in some women, a new technique could reduce radiation for lung nodule patients, a hepatitis treatment may lower cancer recurrence after a procedure, and adding extra screening improves tuberculosis detection in patients with lung infections.

The 2017 issue emphasized progress in laser and energy-based skin treatments, but noted the need for more research on certain procedures and technologies.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Men with early balding should be checked for metabolic syndrome, as there's a link between the two.

Researchers created a system that accurately aligns laser beams automatically.

Taking vitamin D might improve life for MS patients and reduce skin side effects from alemtuzumab treatment.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Photobiomodulation therapy using red and near-infrared light can reduce inflammation and aid in healing various conditions.

The document concludes that non-binary individuals need compassionate support and recognition in healthcare, without being pathologized.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Oral spironolactone's effectiveness for adult female acne is not well-supported by strong evidence.

Some drugs can cause skin, nail, and hair problems, which are important for healthcare professionals to recognize and report.

Skin can be cooled quickly and safely during laser treatments to protect it without affecting deeper layers.

Minoxidil and finasteride effectively treat hair loss.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Hair analysis can detect drug use but requires careful interpretation due to its complexity.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

The article suggests using four questions to tell apart necessary medicalization from excessive medicalization, focusing on problem significance, social expectations, medical understanding, and effective resolution.

Stress from being transgender is linked to higher blood pressure at night and more inflammation, which may affect heart health.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

HPV vaccines are generally safe but need further investigation for rare side effects.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

The authors suggest systematically sourcing new product ideas from various internal and external places to improve innovation.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.